1. |
Guijarro A, Kirchner H, Meguid MM. Catabolic effects of gastric bypass in a dietinduced obese rat model [J]. Curr Opin Clin Nutr Metab Care, 2006, 9(4): 423435.
|
2. |
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic [J]. Nature, 2001, 414(6865): 782787.
|
3. |
Chen CM. Overview of obesity in Mainland China [J]. Obes Rev, 2008, 9 Suppl 1: 1421.
|
4. |
Truesdale KP, Stevens J, Cai J. Effect of 3year weight history on blood pressure: the atherosclerosis risk in communities study [J]. Obesity (Silver Spring), 2008, 16(5): 11121119.
|
5. |
Stevens VJ, Obarzanek E, Cook NR, et al. Longterm weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase Ⅱ [J]. Ann Intern Med, 2001, 134(1): 111.
|
6. |
Dryvold WB, Midthjell K, Nilsen TI, et al. Change in body mass index and its impact on blood pressure: a prospective population study [J]. Int J Obes (Lond), 2005, 29(6): 6506557.
|
7. |
Moore LL, Visioni AJ, Qureshi MM, et al. Weight loss in overweight adults and the longterm risk of hypertension: the Framingham study [J]. Arch Intern Med, 2005, 165(11): 12981303.
|
8. |
Huang Z, Willett WC, Manson JE, et al. Body weight, weight change, and risk for hypertension in women [J]. Ann Intern Med, 1998, 128(2): 8188.
|
9. |
National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-The evidence report [J]. Obes Res, 1998, 6 Suppl 2: 51S209S.
|
10. |
Juhaeri, Stevens J, Chambless LE, et al. Associations between weight gain and incident hypertension in a biethnic cohort: the Atherosclerosis Risk in Communities Study [J]. Int J Obes Relat Metab Disord, 2002, 26(1): 5864.
|
11. |
Field AE, Byers T, Hunter DJ, et al. Weight cycling, weight gain, and risk of hypertension in women [J]. Am J Epidemiol, 1999, 150(6): 573579.
|
12. |
French SA, Jeffery RW, Folsom AR, et al. Weight loss maintenance in young adulthood: prevalence and correlations with health behavior and disease in a populationbased sample of women aged 5569 years [J]. Int J Obes Relat Metab Disord, 1996, 20(4): 303310.
|
13. |
Greenspan P, Mayer EP, Fowler SD. Nile red: a selective fluorescent stain for intracellular lipid droplets [J]. J Cell Biol, 1985, 100(3): 965973.
|
14. |
Visser M, Bouter LM, McQuillan GM, et al. Elevated Ceactive protein levels in overweight and obese adults [J]. JAMA, 1999, 282(22): 21312135.
|
15. |
Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year [J]. Circulation, 2002, 105(7): 804809.
|
16. |
Nigam A, Mitchell GF, Lambert J, et al. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flowmediated dilatation) in patients with and without coronary heart disease [J]. Am J Cardiol, 2003, 92(4): 395399.
|
17. |
Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance [J]. Gastroenterology, 2007, 132(6): 21692180.
|
18. |
Beach KW, Brunzell JD, Strandness DE Jr. Prevalence of severe arteriosclerosis obliterans in patients with diabetes mellitus. Relation to smoking and form of therapy [J]. Arteriosclerosis, 1982, 2(4): 275280.
|
19. |
Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized lowdensity lipoprotein [J]. Nature, 1997, 386(6620): 7377.
|
20. |
Moriwaki H, Kume N, Sawamura T, et al. Ligand specificity of LOX1, a novel endothelial receptor for oxidized low density lipoprotein [J]. Arterioscler Thromb Vasc Biol, 1998, 18(10): 15411547.
|
21. |
Fraley AE, Tsimikas S. Clinical applications of circulating oxidized lowdensity lipoprotein biomarkers in cardiovascular disease [J]. Curr Opin Lipidol, 2006, 17(5): 502509.
|
22. |
Matsuura E, Kobayashi K, Tabuchi M, et al. Oxidative modification of lowdensity lipoprotein and immune regulation of atherosclerosis [J]. Prog Lipid Res, 2006, 45(6): 466486.
|
23. |
Chen J, Mehta JL, Haider N, et al. Role of caspases in OxLDLinduced apoptotic cascade in human coronary artery endothelial cells [J]. Circ Res, 2004, 94(3): 370376.
|
24. |
Imanishi T, Hano T, Sawamura T, et al. Oxidized low density lipoprotein potentiation of Fasinduced apoptosis through lectinlike oxidizedlow density lipoprotein receptor1 in human umbilical vascular endothelial cells [J]. Circ J, 2002, 66(11): 10601064.
|
25. |
Li DY, Zhang YC, Philips MI, et al. Upregulation of endothelial receptor for oxidized lowdensity lipoprotein (LOX1) in cultured human coronary artery endothelial cells by angiotensin Ⅱ type 1 receptor activation [J]. Circ Res, 1999, 84(9): 10431049.
|
26. |
Kume N, Murase T, Moriwaki H, et al. Inducible expression of lectinlike oxidized LDL receptor1 in vascular endothelial cells [J]. Circ Res, 1998, 83(3): 322327.
|
27. |
Murase T, Kume N, Korenaga R, et al. Fluid shear stress transcriptionally induces lectinlike oxidized LDL receptor1 in vascular endothelial cells [J]. Circ Res, 1998, 83(3): 328333.
|
28. |
Chen M, Nagase M, Fujita T, et al. Diabetes enhances lectinlike oxidized LDL receptor1 (LOX1) expression in the vascular endothelium: possible role of LOX1 ligand and AGE [J]. Biochem Biophys Res Commun, 2001, 287(4): 962968.
|
29. |
Steinbrook R. Surgery for severe obesity [J]. N Engl J Med, 2004, 350(11): 10751079.
|
30. |
Pinkney JH, Sjstrm CD, Gale EA. Should surgeons treat diabetes in severely obese people? [J]. Lancet, 2001, 357(9265): 13571359.
|
31. |
Dixon JB, Pories WJ, O’Brien PE, et al. Surgery as an effective early intervention for diabesity: why the reluctance? [J]. Diabetes Care, 2005, 28(2): 472474.
|
32. |
Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years [J]. Obes Surg, 2006, 16(11): 14501456.
|
33. |
Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients [J]. Obes Surg, 2005, 15(10): 14691475.
|
34. |
Roa PE, KaidarPerson O, Pinto D, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and shortterm outcome [J]. Obes Surg, 2006, 16(10): 13231326.
|
35. |
Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptideYY levels after RouxenY gastric bypass and sleeve gastrectomy: a prospective, double blind study [J]. Ann Surg, 2008, 247(3): 401407.
|